12/1/2025 On November 6, 2025, the Trump administration announced a landmark agreement with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to provide steep discounts on their most popular GLP-1 medications, cuts that will benefit Medicare and Medicaid enrollees as well as cash-paying patients
They studied patients in SELECT for about 4 years, giving half of them Wegovy and half of them placebo
Indeed, Type-2 diabetics usually gain weight when they start taking insulin
(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al
Issa N M, El-Sherif N M
I have found that patients don't tell me that their drug is really expensive and if I switched them, it would've been cheaper
